Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2848799 | American Heart Journal | 2016 | 9 Pages |
Abstract
Despite randomized trial evidence and guideline recommendations, only a minority of Canadian MI patients undergoing PCI initially received or were discharged on one of the newer ADPri agents. These findings suggest an opportunity to improve upon the appropriate selection of the ADPris at index hospitalization and discharge in Canadian MI patients undergoing PCI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jean-Pierre MD, MSc, Shamir R. MD, MSc, Harold N. MD, Xiang PhD, Yajun Emily MSc, Robert C. MD, Shahar MD, Tomas MD, Mark A. MD, Sohrab MD, CM, Anthony J. Della MD, Asim N. MD, Brian Y.L. MD, Andre MD, Payam MD, Shaun G. MD, MSc,